AT
Anat Tomer
Qa&Ra Director at Cormed
View Anat's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Qa&Ra Director
Jun 2024 - Present · 6 months
Director Of Quality Assurance
Dec 2016 - Present · 8 years
Vp Quality & Regulatory Affairs
Jan 2023 - Aug 2024 · 1 years and 7 months
Company Details
51-200 Employees
CORMED is a leading company in the healthcare industry, specializing in closed system drug transfer devices (CSTDs) for the safe handling of hazardous drugs. Our mission is to provide healthcare professionals and patients with the highest level of protection against the potential risks associated with unintended exposure to hazardous drugs and their vapor. Safe Professionals, Safe Patients! Our product the HALO® CSTD has been evaluated and meets the highest standard for vapor and fluid containment, prohibits microbial ingress. Each HALO® component is airtight and leak proof, intuitive and easy to use, compatible and efficient with your pharmacy workflow. Designed for simplicity and comfort, the HALO® has fewer pieces and offers smooth and single motion connections. HALO® CSTD was thoughtfully developed & designed with one major focus: YOU, the end user. At Cormed, we strongly believe that customer satisfaction is directly linked to the level of excellence in our products. We place a significant emphasis on producing high-quality products. Our products are FDA cleared and complying with the strictest regulatory requirements under our ISO 13485 quality system management.
Year Founded
2022
Social Media
Linkedin
Industry
Medical Equipment Manufacturing
HQ Location
3 Pearl Ct Allendale, New Jersey 07401, US
Keywords
CSTDMedical DeviceMedical ManufacturingHazardous Drug ManagementsHospital PharmacistsOncology Nursingand Close System Drug Transfer Device
Discover More About Cleveland Clinic

Find verified contacts of Anat Tomer in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.